Prognostic Role of Circulating Tumor DNA in Resectable Pancreatic Cancer
Clinical trial NCT04246203 · ACTIVE_NOT_RECRUITING
Trial details
- NCT number
- NCT04246203
- Sponsor
- Ludwig-Maximilians - University of Munich
- Status
- ACTIVE_NOT_RECRUITING
- Study type
- OBSERVATIONAL
- Start date
- 2021-12-12
- Primary completion
- 2025-12-01
- Enrollment
- 200
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.